Jonathan Young, Chief Operating Officer at Akero Therapeutics, Inc. (AKRO), sold 4,986 shares at $53.99 ($269K) on 2025-06-10, disclosed to the SEC on 2025-06-12.
Open-market sale of $269k AKRO by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.99 | 2,493 | $135K | 50.0% |
| 2 | $53.99 | 2,493 | $135K | 50.0% |
| Total | $53.99 avg | 4,986 | $269K | 100% |
| Filing → |
| AKRO | SELL | 2025-09-04 | $705K | — | Filing → |
| AKRO | SELL | 2025-08-13 | $1.2M | — | Filing → |
| AKRO | SELL | 2025-06-20 | $159K | — | Filing → |